Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

To Study the Safety and Pharmacokinetics of BLYG8824A in Patients with Locally Advanced or Metastatic Colorectal Cancers Ended

2023-503409-12-00 Locally Advanced or Metastatic Colorectal Cancers (mCRC 1 2020-10-26
Study to evaluate the efficacy and safety of cetuximab plus irinotecan compared to investigator's choice therapy in patients with metastatic… Ended

2024-518728-59-00 metastatic colorectal cancer 4 2020-10-23
A Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Forimtamig in Participants With Relapsed or Refractory Multiple My… Ended

2023-504571-25-00 Relapsed or Refractory Multiple Myeloma 3 2020-10-20
Substudy to test investigational agents with pembrolizumab in combination with chemotherapy in treatment-naïve NSCLC in a rolling arm design Ended

2023-506932-33-00 non-small cell lung cancer 4 2020-10-20
Substudy to test investigational agents in combination with pembrolizumab in PD-L1 positive treatment-naïve NSCLC in a rolling arm design Ended

2023-506933-32-00 Non-small Cell Lung Cancer (NSCLC) 4 2020-10-20
Substudy to test investigational agents in combination with pembrolizumab in patients with PD-(L)1 refractory NSCLC in a rolling-arm design Ended

2023-506934-56-00 Non-small Cell Lung Cancer 4 2020-10-20
A Clinical Study to Compare the Effectiveness and Safety of Pevonedistat, Venetoclax, and Azacitidine Versus Venetoclax Plus Azacitidine in … Ended

2024-515424-36-00 Acute Myeloid Leukemia 4 2020-10-15
IFCT-1802 SAVIMMUNE: Immunotherapy in Patient With Poor General Condition Ended

2024-515943-44-00 Non small cell lung cancer 4 2020-10-14
A Study to Evaluate the Efficacy and Safety of Atezolizumab Given in Combination with Cabozantinib Versus Cabozantinib Alone in Patients wit… Ended

2024-517785-42-00 Renal cell carcinoma (RCC) 5 2020-10-08
Study of Sacituzumab Govitecan’s Long-Term Safety in Subjects with Metastatic Solid Tumors Ended

2023-505336-34-00 Metastatic solid tumors 6 2020-10-08
A Study of Oral Tazemetostat in Subjects With Moderate and Severe Liver Impairment With Advanced solid tumors or hematological malignancies Ended

2024-517141-13-00 Advanced solid tumors, or hematological malignancies an 3 2020-10-07
A Randomized, Double Blind, Phase 3 Study of Platinum-Based Chemotherapy With or Without INCMGA00012 in First-Line Metastatic Squamous and N… Ended

2022-501987-16-00 Metastatic nonsquamous or squamous non-small cell lung 5 2020-10-02
TAS102 in patients with ER-positive, HER2-negative advanced breast cancer (TIBET study) Ended

2024-519204-27-00 Advanced breast cancer 4 2020-09-25
Study to assess the efficacy and safety of alpelisib (BYL719) in combination with trastuzumab and pertuzumab as maintenance therapy in patie… Ended

2024-512050-13-00 HER2-positive advanced breast cancer 5 2020-09-22
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cel… Ended

2022-502480-38-00 Non−small cell lung cancer (NSCLC) 5 2020-09-09
“A randomized phase II trial to evaluate the antitumor activity of Enzalutamide and Talazoparib (PF-06944076) for the treatment of metastati… Ended

2023-509387-24-00 Metastatic hormone–naïve prostate cancer (mHNPC) 4 2020-09-02
A study to assess how radium-223 moves through the patients with prostate cancer receiving radium-223 dichloride treatment. Ended

2023-506435-15-00 Prostate cancer 3 2020-08-25
Clinical safety study on 5-Aminolevulinic acid (5-ALA) in children and adolescents with brain tumors Ended

2024-517575-20-00 different types of brain tumors 4 2020-08-24
SAR408701 versus docetaxel in previously treated, carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) positive metastatic no… Ended

2024-515101-26-00 Non-small cell lung cancer metastatic 5 2020-08-21
Double-blind (neither the patient nor the doctor knows treatment allocation of the patient), randomized, placebo-controlled, prospective pha… Ended

2023-509737-39-00 Primary infection prophylaxis in patients with chronic 5 2020-08-19
Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy versus systemic chemotherapy alone as 1s… Ended

2024-515343-39-00 Malignant Peritoneal Mesothelioma 4 2020-08-14
Study to evaluate the effect of metformin in the prevention of hyperglycemia in HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients… Ended

2024-511295-33-00 Study to evaluate the effect of metformin in the preven 4 2020-08-13
A Randomized Phase 2 Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Subjects Who Received Bacillus Calmette… Ended

2023-510306-40-00 Cohort 1 and 2: High Risk Non-Muscle-Invasive Bladder C 4 2020-08-11
A study of safety and efficacy of novel targeted therapy combinations in adult patients with advanced or metastatic colorectal cancer. Ended

2023-510379-77-00 Advanced or metastatic BRAF V600 colorectal cancer. 3 2020-08-05